Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV)’s share price traded up 2.9% during trading on Friday . The company traded as high as $3.25 and last traded at $3.21, with a volume of 72,808 shares traded. The stock had previously closed at $3.12.

A number of equities analysts have recently commented on the stock. Rodman & Renshaw reaffirmed a “buy” rating on shares of Kitov Pharmaceuticals Holdings in a report on Saturday, May 14th. Zacks Investment Research raised shares of Kitov Pharmaceuticals Holdings from a “hold” rating to a “buy” rating and set a $3.25 price objective for the company in a report on Wednesday, July 13th.

The stock’s market capitalization is $12.53 million. The stock’s 50-day moving average is $3.07 and its 200 day moving average is $3.98.

Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.